The immune response after stimulation with wall components of gram-positive bacteria and fungi

Vincent, 2006, Sepsis in European intensive care units: results of the SOAP study, Crit Care Med, 34, 344, 10.1097/01.CCM.0000194725.48928.3A Sarnak, 2000, Mortality caused by sepsis in patients with end-stage renal disease compared with the general population, Kidney Int, 58, 1758, 10.1111/j.1523-1755.2000.00337.x Schuetz, 2011, Diabetes and sepsis reclinical findings and clinical relevance, Diabetes Care, 34, 771, 10.2337/dc10-1185 Castellheim, 2009, Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis, Scand J Immunol, 69, 479, 10.1111/j.1365-3083.2009.02255.x Rudiger, 2008, Cellular processes in sepsis, Swiss Med Wkly, 138, 629 Ingalls, 1999, Lypopolysaccharide recognition, CD14 and lipopolysaccharide receptors, Infect Dis Clin North Am, 13, 341, 10.1016/S0891-5520(05)70078-7 Wang, 2000, Peptidoglycan and lipoteichoic acid from staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model, Infect Immun, 68, 3965, 10.1128/IAI.68.7.3965-3970.2000 Nelson, 1991, Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action, Clin Microbiol Rev, 4, 1, 10.1128/CMR.4.1.1 Monneret, 2011, ICU-acquired immunosuppression and the risk for secondary fungal infections, Med Mycol, 49, S17, 10.3109/13693786.2010.509744 American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864–74. National Kidney Foundation, 2002, K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, Am J Kidney Dis, 39, S1 Standards of medical care in Diabetes-2011. Diabetes Care 2011; 34:S11. Myrianthefs, 2004, LPS tolerance in septic ICU patients: laboratory and technical considerations, Surg Infect, 5, 63, 10.1089/109629604773860327 Fildissis, 2004, Whole blood pro-inflammatory cytokines and adhesion molecules post-lipopolysaccharides exposure in hyperbaric conditions, Eur Cytokine Netw, 15, 217 Ginsburg, 2002, Role of lipoteichoic acid in infection and inflammation, Lancet Infect Dis, 2, 171, 10.1016/S1473-3099(02)00226-8 Netea, 2006, Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and toll-like receptors, J Clin Invest, 116, 1642, 10.1172/JCI27114 Myrianthefs, 2003, Seasonal variation in whole blood cytokine production after LPS stimulation in normal individuals, Cytokine, 24, 286, 10.1016/j.cyto.2003.08.005 Webb, 2002, The role of mediators in sepsis resolution, Adv Sepsis, 2, 8 Stenvinkel, 2005, IL-10, IL-6, and TNF-a: central factors in the altered cytokine network of uremia - the good, the bad, and the ugly, Kidney Int, 67, 1216, 10.1111/j.1523-1755.2005.00200.x Amore, 2002, Immunological basis of inflammation in dialysis, Nephrol Dial Transplant, 17, 16, 10.1093/ndt/17.suppl_8.16 Vanholder, 1996, Influence of uraemia and haemodialysis on host defence and infection, Nephrol Dial Transplant, 11, 593, 10.1093/oxfordjournals.ndt.a027346 Kato, 2008, Aspects of immune dysfunction in end-stage renal disease, Clin J Am Soc Nephrol, 3, 1526, 10.2215/CJN.00950208 Kimmel, 1998, Immunologic function and survival in hemodialysis patients, Kidney Int, 54, 236, 10.1046/j.1523-1755.1998.00981.x Knerr K, 2005, Chronic inflammation and hemodialysis reduce immune competence of peripheral blood leukocytes in end-stage renal failure patients, Cytokine, 30, 132, 10.1016/j.cyto.2004.12.011 Pickup, 2000, Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes, Life Sci, 67, 291, 10.1016/S0024-3205(00)00622-6 Oda, 2005, Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis, Cytokine, 29, 169, 10.1016/j.cyto.2004.10.010 Rodríguez-Gaspar, 2001, Prognostic value of cytokines in SIRS general medical patients, Cytokine, 15, 232, 10.1006/cyto.2001.0932 Roumen, 1993, Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure, Ann Surg, 218, 769, 10.1097/00000658-199312000-00011 Gogos, 2000, Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options, J Infect Dis, 181, 176, 10.1086/315214 Monneret, 2008, Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony, Mol Med, 14, 64, 10.2119/2007-00102.Monneret Boomer, 2011, Immunosuppression in patients who die of sepsis and multiple organ failure, JAMA, 306, 2594, 10.1001/jama.2011.1829 Cavaillon, 2006, Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis, Critical Care, 10, 233, 10.1186/cc5055 Riedel, 2000, Differential tolerance induction by lipoarabinomannan and lipopolysaccharide in human macrophages, Microb Infect, 2, 463, 10.1016/S1286-4579(00)00319-1 Frazier, 2008, Immunoparalysis and adverse outcomes from critical illness, Pediatr Clin North Am, 55, 647, 10.1016/j.pcl.2008.02.009 Nakos, 2002, Immunoparalysis in patients with severe trauma and the effect of inhaled interferon-gamma, Crit Care Med, 30, 1488, 10.1097/00003246-200207000-00015 Myrianthefs, 2010, Diagnostic coronary angiography is related to decreased TNF-a production after ex-vivo whole blood stimulation with LPS, Cytokine, 51, 87, 10.1016/j.cyto.2010.03.012 Draisma, 2009, Development of endotoxin tolerance in humans in vivo, Crit Care Med, 37, 1261, 10.1097/CCM.0b013e31819c3c67 Allen, 2006, Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery, Crit Care Med, 34, 2658, 10.1097/01.CCM.0000240243.28129.36 Netea, 2006, Role of the dual interaction of fungal pathogens with pattern recognition receptors in the activation and modulation of host defence, Clin Microbiol Infect, 12, 404, 10.1111/j.1469-0691.2006.01388.x Yaqoob, 1998, Comparison of cytokine production in cultures of whole human blood and purified mononuclear cells, Cytokine, 11, 600, 10.1006/cyto.1998.0471 Hochart, 2005, Low-molecular weight and unfractionated heparins induce a downregulation of inflammation: decreased levels of proinflammatory cytokines and nuclear factor-(B in LPS-stimulated human monocytes, Brit J Haematol, 133, 62, 10.1111/j.1365-2141.2006.05959.x de Jager, 2009, Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays, BMC Immunol, 10, 52, 10.1186/1471-2172-10-52